Communities Fighting COVID-19!
Study Details
Study Description
Brief Summary
To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Communities Fighting COVID is a partnership between San Diego State's School of Public Health and numerous communities in San Diego focused on providing community-based testing to specific language-speaking communities and vulnerable populations. This partnership is funded by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics-Undeserved Populations (Radx-UP), with the aim of ensuring all Americans have access to timely COVID-19 testing and diagnosis. Many communities, particularly immigrant and people of color communities, have a harder time accessing existing COVID-19 resources due to transportation, language barriers, or other barriers.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: At home testing (Aim 1) High-risk friends and family of contacts exposed to COVID-19 will be provided with COVID-19 testing provided at home by a healthcare worker. |
Other: COVID-19 Testing Home-based (Aim 1)
Implementation of Antigen and PCR testing at participant homes
|
| Active Comparator: Mobile testing (Aim 1) High-risk friends and family of contacts exposed to COVID-19 will be referred to study operated mobile testing sites in the community for COVID-19 testing. |
Other: COVID-19 Testing Mobile (Aim 1)
Implementation of Antigen and PCR testing at mobile test sites
|
| Other: Mobile testing approach 1 (Aim 2) Mobile testing utilizing active outreach |
Other: COVID-19 Testing Mobile Approach 1 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - active outreach
|
| Other: Mobile testing approach 2 (Aim 2) Mobile testing utilizing baseline outreach approaches |
Other: COVID-19 Testing Mobile Approach 2 (Aim 2)
Implementation of Antigen and PCR testing at mobile test sites - baseline outreach
|
Outcome Measures
Primary Outcome Measures
- Test uptake [Through study completion, expected to be 20 months]
Testing volume by study arm as cumulative count per hours testing site operated
Secondary Outcome Measures
- Test access [Through study completion, expected to be 20 months]
Proportion of individuals by study arm who note that this strategy has facilitated ability to test.
- Test Impact (COVID-19 diagnoses) [Through study completion, expected to be 20 months]
Proportion of COVID-19 diagnoses of those tested by study arm
- Test Impact (number needed to screen) [Through study completion, expected to be 20 months]
Number needed to screen (number tested in order to detect one new infection).
Eligibility Criteria
Criteria
Inclusion Criteria:
- African American, Arabic speaking, Filipino, and Latino/a populations
Exclusion Criteria:
- Younger than 6, not in focus populations
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Contact Households | San Diego | California | United States | 92182 |
Sponsors and Collaborators
- San Diego State University
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Susan M Kiene, PhD, San Diego State University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HS-2020-0186
- 3U54CA132384-10S1